Comments on the development of inhibitor antibodies in patients using recombinant factor VIII concentrates.
Brettler
D B
DB
Memorial Hospital, Worcester, MA.
D000328:Adult; D000917:Antibody Formation; D002675:Child, Preschool; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D006801:Humans; D008297:Male; D010375:Pedigree; D011993:Recombinant Fusion Proteins / Q000276:immunology* / Q000627:therapeutic use
D011993:Recombinant Fusion Proteins; D005169:Factor VIII